Semi Harrabi
Overview
Explore the profile of Semi Harrabi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luhr A, Wagenaar D, Eekers D, Glimelius L, Habraken S, Harrabi S, et al.
Phys Imaging Radiat Oncol
. 2025 Jan;
33():100692.
PMID: 39839817
Background And Purpose: In proton therapy, a relative biological effectiveness (RBE) of 1.1 is used to convert proton dose into an equivalent photon dose. However, RBE varies with tissue type,...
2.
Schweins L, Kirchgassner R, Ochoa-Parra P, Winter M, Harrabi S, Mairani A, et al.
Med Phys
. 2024 Dec;
PMID: 39714780
Background: Carbon-ion radiotherapy provides steep dose gradients that allow the simultaneous application of high tumor doses as well as the sparing of healthy tissue and radio-sensitive organs. However, even small...
3.
Osburg A, Lysakovski P, Magro G, Harrabi S, Haberer T, Abdollahi A, et al.
Phys Imaging Radiat Oncol
. 2024 Dec;
32:100679.
PMID: 39687466
Background And Purpose: In carbon ion radiotherapy (CIRT), different relative biological effectiveness (RBE) models have been used for calculating RBE-weighted dose (D). Conversion between current RBE predictions and introduction of...
4.
Meixner E, Wermes L, Hoeltgen L, von Diest L, Sandrini E, Harrabi S, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682174
: Definitive radiochemotherapy with concomitant cisplatin 40 mg/m weekly represents the standard of care for locally advanced cervical cancer. Current studies (KEYNOTE-A18 and INTERLACE) are intensifying this regimen at the...
5.
Meixner E, Hoeltgen L, Dinges L, Harrabi S, Seidensaal K, Weykamp F, et al.
Strahlenther Onkol
. 2024 Nov;
PMID: 39531126
Purpose: The appearance of symptomatic tumor-related vaginal bleeding and pain in advanced incurable cancer patients with pelvic gynecological malignancies remains a therapeutic challenge in oncological treatment. The aim of our...
6.
Meixner E, Glogauer B, Kluter S, Wagner F, Neugebauer D, Hoeltgen L, et al.
Clin Transl Radiat Oncol
. 2024 Sep;
49:100855.
PMID: 39308634
Introduction: Target volume delineation is routinely performed in postoperative radiotherapy (RT) for breast cancer patients, but it is a time-consuming process. The aim of the present study was to validate...
7.
Ochoa-Parra P, Schweins L, Abbani N, Ghesquiere-Dierickx L, Gehrke T, Jakubek J, et al.
Med Phys
. 2024 Sep;
51(12):9217-9229.
PMID: 39306865
Background: In-vivo monitoring methods of carbon ion radiotherapy (CIRT) includes explorations of nuclear reaction products generated by carbon-ion beams interacting with patient tissues. Our research group focuses on in-vivo monitoring...
8.
Janke F, Stritzke F, Dvornikovich K, Franke H, Angeles A, Riediger A, et al.
Int J Cancer
. 2024 Aug;
156(4):853-864.
PMID: 39212345
Local recurrence after radiotherapy is common in locally advanced head and neck cancer (HNC) patients. Re-irradiation can improve local disease control, but disease progression remains frequent. Hence, predictive biomarkers are...
9.
Kelleter L, Marek L, Echner G, Ochoa-Parra P, Winter M, Harrabi S, et al.
Sci Rep
. 2024 Jul;
14(1):15452.
PMID: 38965349
Ion-beam radiotherapy is an advanced cancer treatment modality offering steep dose gradients and a high biological effectiveness. These gradients make the therapy vulnerable to patient-setup and anatomical changes between treatment...
10.
Toussaint L, Matysiak W, Alapetite C, Aristu J, Bannink-Gawryszuk A, Bolle S, et al.
Radiother Oncol
. 2024 Jun;
198:110414.
PMID: 38942120
Background And Purpose: As no guidelines for pencil beam scanning (PBS) proton therapy (PT) of paediatric posterior fossa (PF) tumours exist to date, this study investigated planning techniques across European...